These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 28329774)
61. Rs12778366 single nucleotide polymorphism of Sirtuin 1 (SIRT1) and response to resveratrol supplementation in patients with type 2 diabetes mellitus. Gambino R; Fanni G; Togliatto G; Ponzo V; Goitre I; Cassader M; Brizzi MF; Bo S Acta Diabetol; 2019 Aug; 56(8):963-966. PubMed ID: 30980188 [No Abstract] [Full Text] [Related]
62. Sirtuin-1 in immunotherapy: A Janus-headed target. Chadha S; Wang L; Hancock WW; Beier UH J Leukoc Biol; 2019 Aug; 106(2):337-343. PubMed ID: 30605226 [TBL] [Abstract][Full Text] [Related]
63. Sirtuin function and metabolism: Role in pancreas, liver, and adipose tissue and their crosstalk impacting bone homeostasis. Avilkina V; Chauveau C; Ghali Mhenni O Bone; 2022 Jan; 154():116232. PubMed ID: 34678494 [TBL] [Abstract][Full Text] [Related]
65. Renal protective effect of sirtuin 1. Dong YJ; Liu N; Xiao Z; Sun T; Wu SH; Sun WX; Xu ZG; Yuan H J Diabetes Res; 2014; 2014():843786. PubMed ID: 25386563 [TBL] [Abstract][Full Text] [Related]
66. SIRT1: a promising therapeutic target in type 2 diabetes mellitus. Mihanfar A; Akbarzadeh M; Ghazizadeh Darband S; Sadighparvar S; Majidinia M Arch Physiol Biochem; 2024 Feb; 130(1):13-28. PubMed ID: 34379994 [TBL] [Abstract][Full Text] [Related]
67. Plasma levels of sirtuin-1 in patients with cerebrovascular stroke. Esmayel IM; Hussein S; Gohar EA; Ebian HF; Mousa MM Neurol Sci; 2021 Sep; 42(9):3843-3850. PubMed ID: 33507417 [TBL] [Abstract][Full Text] [Related]
68. Activators of Sirtuin-1 and their Involvement in Cardioprotection. Granchi C; Minutolo F Curr Med Chem; 2018; 25(34):4432-4456. PubMed ID: 29446717 [TBL] [Abstract][Full Text] [Related]
69. SIRT1 in neurodevelopment and brain senescence. Herskovits AZ; Guarente L Neuron; 2014 Feb; 81(3):471-83. PubMed ID: 24507186 [TBL] [Abstract][Full Text] [Related]
70. Sirtuin 1 as the mechanism of action of agents used in the diabetes mellitus pharmacotherapy. Stelmaszyk A; Mikołajczak P; Dworacka M Eur J Pharmacol; 2021 Sep; 907():174289. PubMed ID: 34214583 [TBL] [Abstract][Full Text] [Related]
71. SIRT1 Expression and Regulation in the Primate Testis. Wahab F; Rodriguez Polo I; Behr R Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809872 [TBL] [Abstract][Full Text] [Related]
72. Synthesis and Assay of SIRT1-Activating Compounds. Dai H; Ellis JL; Sinclair DA; Hubbard BP Methods Enzymol; 2016; 574():213-244. PubMed ID: 27423864 [TBL] [Abstract][Full Text] [Related]
73. Role of Sirtuin 1 in the pathogenesis of ocular disease (Review). Zhou M; Luo J; Zhang H Int J Mol Med; 2018 Jul; 42(1):13-20. PubMed ID: 29693113 [TBL] [Abstract][Full Text] [Related]
74. Dietary proanthocyanidins boost hepatic NAD(+) metabolism and SIRT1 expression and activity in a dose-dependent manner in healthy rats. Aragonès G; Suárez M; Ardid-Ruiz A; Vinaixa M; Rodríguez MA; Correig X; Arola L; Bladé C Sci Rep; 2016 Apr; 6():24977. PubMed ID: 27102823 [TBL] [Abstract][Full Text] [Related]
75. A pharmacological review on SIRT 1 and SIRT 2 proteins, activators, and inhibitors: Call for further research. Nandave M; Acharjee R; Bhaduri K; Upadhyay J; Rupanagunta GP; Ansari MN Int J Biol Macromol; 2023 Jul; 242(Pt 1):124581. PubMed ID: 37105251 [TBL] [Abstract][Full Text] [Related]